drugset / Trial / NCT02790164

Summary

The main purpose of this study is to test the hypothesis that continuous NMB could improve outcome in cardiac arrest patients treated with therapeutic hypothermia.

Timeline

Start
2016-05
Primary completion
2016-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.3 mg/kg Intravenous
Subject Rocuronium Other / unclassified 0.6 mg/kg Intravenous

Indications